PMA device
Optune Pax
Novocure, GmbH · Low Electric Field Generator For Pancreatic Cancer Treatment (SHC, Class III) · First FDA decision Feb 11, 2026, newest Feb 11, 2026Pancreatic and bile duct disease
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
Breakthrough-designated
Device trials
0
Naming "Optune Pax"
MAUDE reports
10
Brand "Optune Pax", since 2015
PubMed studies
1
Mentioning "Optune Pax"
AI summary across all sources
Written by Claude (Anthropic's AI) from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Optune PaxBreakthroughPMA
P250034 · Decided Feb 11, 2026 · 180 days after receipt
Device type: Low Electric Field Generator for Pancreatic Cancer Treatment (SHC) · General & Plastic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Autologous Cellular Immunotherapy Treatment of Metastatic Prostate CancerNational analysisReview closedCAG-00422NUpdated Nov 19, 2026
- Electrical Stimulation (ES) and Electromagnetic Therapy for the Treatment of WoundsNational determinationOn the books270.1Updated Nov 4, 2026
- Positron Emission Tomography (FDG) for Brain, Cervical, Ovarian, Pancreatic, Small Cell Lung, and Testicular CancersNational analysisReview closedCAG-00181NUpdated Sep 21, 2026
- Abarelix for the Treatment of Prostate CancerNational analysisReview closedCAG-00238NUpdated Sep 15, 2026
- FDG PET for Brain, Cervical, Ovarian, Pancreatic, Small Cell Lung, and Testicular Cancers (Replaced with Section 220.6.17) - RETIREDNational determinationOn the books220.6.14Updated Jun 7, 2024
- Treatment of Motor Function Disorders with Electric Nerve StimulationNational determinationOn the books160.2Updated Aug 17, 2023
- Electrical Aversion Therapy for Treatment of AlcoholismNational determinationOn the books130.4Updated Jun 10, 2020
- Hyperthermia for Treatment of CancerNational determinationOn the books110.1Updated Apr 17, 2020
Clinical trials
Device studies on ClinicalTrials.gov that name "Optune Pax", any status and sponsor, newest update first.
No registered device study names "Optune Pax".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Optune Pax", and for the whole product code for context.
This brand
10 reports: 0 malfunction, 10 injury, 0 death
Whole product code SHC
10 reports: 0 malfunction, 10 injury, 0 death
Newest reports for this brand
- Optune PaxInjury
3010457505-2026-00890 · Received Oct 14, 2026 · Event dated Jul 17, 2026
Device type: Low Electric Field Generator For Pancreatic Cancer Treatment (SHC)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Itching Sensation
- Optune PaxInjury
3010457505-2026-00881 · Received Oct 2, 2026 · Event dated Aug 19, 2026
Device type: Low Electric Field Generator For Pancreatic Cancer Treatment (SHC)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Itching Sensation; Skin Inflammation/ Irritation
- Optune PaxInjury
3010457505-2026-00863 · Received Sep 18, 2026 · Event dated Aug 21, 2026
Device type: Low Electric Field Generator For Pancreatic Cancer Treatment (SHC)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Skin Inflammation/ Irritation
- Optune PaxInjury
3010457505-2026-00813 · Received Jul 27, 2026 · Event dated Jun 1, 2026
Device type: Low Electric Field Generator For Pancreatic Cancer Treatment (SHC)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Skin Inflammation/ Irritation
- OPTUNE PAXInjury
3010457505-2026-00792 · Received Jul 2, 2026 · Event dated Jun 3, 2026
Device type: Low Electric Field Generator For Pancreatic Cancer Treatment (SHC)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Fatigue
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Optune Pax"[tiab]. The summary above synthesizes these.
- In brief: Optune Pax - a portable device for pancreatic cancer.
Med Lett Drugs Ther · 2026
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.